14604755•Private Limited With Share Capital
Get Full Access
19/01/2023
3 years
3
2
72110
moderate risk
Registration, classification & business activity
Rhino Therapeutics Limited (14604755) is a private limited with share capital incorporated on 19/01/2023 (3 years old) and registered in cheltenham, GL503PR. The company operates under SIC code 72110 - research and experimental development on biotechnology.
£1.26M
£607.5K
£657.0K
£3.04M
£28.9K
2
Employees
3
Directors
1
Shareholders
This company received a grant of £464778.0 for Rhino Therapeutics: Pre-Clinical Model Development And Efficacy Testing Of The First Disease-Modifying Therapy Globally To Restore Sensorineural Olfactory Loss And Improve Patient Outcomes And Quality Of Life. The project started on 01/06/2025 and ended on 31/07/2026.
moderate risk
International Score
fair
Performance Rating